LENZ Therapeutics has made a groundbreaking stride by submitting a Marketing Authorization Application to the UK’s Medicines and Healthcare products Regulatory Agency for VIZZ®, a revolutionary new treatment for presbyopia. This pivotal milestone brings the thrilling possibility of VIZZ® becoming available to patients in the UK closer than ever!